News | March 14, 2026
Curatis and Neupharma strike major deal to bring brain tumor therapy to Japan
Neupharma gains exclusive rights to develop and commercialize corticorelin for peritumoral brain edema
Neupharma gains exclusive rights to develop and commercialize corticorelin for peritumoral brain edema
Swayam is designed to support elderly patients and their families with seamless access to coordinated medical care
The initiative, funded entirely under the company’s CSR programme, is expected to reach over a million lives
Bosentan 32 mg tablets for oral suspension are indicated for the treatment of Pulmonary Arterial Hypertension
Duvakitug was well tolerated and safety was consistent with the induction study
Emcure becomes the first Indian company to exclusively distribute and commercialise Poviztra, a second brand of Novo Nordisk’s Semaglutide injection for weight management
Travoprost ophthalmic solution is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension
WINREVAIR is currently the first and only activin signalling inhibitor approved for PAH across all 27 EU member states
It's a development that marks a major step forward for patients struggling with moderate-to-severe chronic spontaneous urticaria
Elevidys came under scrutiny in June when the FDA disclosed two fatal cases in non-ambulatory boys who developed dangerously high liver enzyme levels
Subscribe To Our Newsletter & Stay Updated
